Prime Minister Scott Morrison should apologise to former Australia Post CEO Christine Holgate for leveling an “improper threat” during a Senate hearing last year that she should “stand aside or go” for purchasing $5,000 Cartier watches as bonuses for four employees.
Ben Roberts-Smith has won approval to split his case at the upcoming trial in his defamation case against three publishers over articles accusing him of war crimes, with a judge saying the seriousness of the allegations against him weighed in favour of the unorthodox move.
Former attorney-general Christian Porter has dodged a question about whether his defamation lawsuit against the ABC and reporter Louise Milligan is being funded by third parties, saying he went into the litigation knowing the case would be a “massive drain” on his finances.
The High Court has denied the ATO’s request that it weigh in on Australia’s transfer pricing regime, leaving in place a Full Court victory for mining giant Glencore that left it paying $2 million of a $92 million bill relating to the sale of copper from a mine in Cobar, NSW.
Arnott’s and Campbells have settled a lawsuit brought by Goodman Fielder accusing them of infringing its ‘Plantry’ mark under which it sells plant-based frozen meals, after the cookie company filed a cross-claim seeking to have the mark cancelled.
One of the lead applicants in a settled shareholder class action against technology company Arasor wants to set aside a statutory demand from funder International Litigation Partners, reviving a years-long beef over $1.2 million allegedly owed in personal expenses under a side agreement agreement with the funder.
The High Court has ordered mining magnate Clive Palmer to pay Western Australia Premier Mark McGowan’s costs for contempt proceedings brought against him during the war of words that erupted between the pair over the state’s decision to close its borders at the height of the coronavirus pandemic last year.
Juno Pharmaceuticals has backed away from its plans to launch a generic version of HIV drug Prezista in Australia after being hit with a patent lawsuit by Janssen, becoming the second generic drug maker to capitulate to the Johnson & Johnson-owned company’s demands.
Grant Thornton has won approval to a bring a cross-claim against Forge Group, just three months ahead of trial in the collapsed engineering company’s case against the accounting firm and ten former directors for their alleged negligence in relation to its “uneconomic” purchase of CTEC in 2012.
A former executive of hospital operator Healthe Care Pty has pleaded guilty to one charge of insider trading for acquiring a large number of shares in Pulse Health while in possession of inside information about the private hospital operator.